<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id><journal-title-group><journal-title>BMC Cancer</journal-title></journal-title-group><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27825320</article-id><article-id pub-id-type="pmc">5101649</article-id><article-id pub-id-type="publisher-id">2896</article-id><article-id pub-id-type="doi">10.1186/s12885-016-2896-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Improved nutrition in adolescents and young adults after childhood cancer&#x000a0;- INAYA study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7419-7449</contrib-id><name><surname>Quidde</surname><given-names>J.</given-names></name><address><phone>+49-40-7410 18169</phone><email>j.quidde@uke.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>von Grundherr</surname><given-names>J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Koch</surname><given-names>B.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bokemeyer</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Escherich</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Valentini</surname><given-names>L.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Buchholz</surname><given-names>D.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schilling</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Stein</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Oncology, Hematology, BMT with Section Pneumology, Hubertus Wald Tumour Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany </aff><aff id="Aff2"><label>2</label>Hochschule Neubrandenburg - University of Applied Sciences, Fachbereich Agrarwirtschaft und Lebensmittelwissenschaften, Brodaer Stra&#x000df;e 2, 17033 Neubrandenburg, Germany </aff><aff id="Aff3"><label>3</label>Department of Paediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany </aff><aff id="Aff4"><label>4</label>Hamburger Krebsgesellschaft e.V., Butenfeld 18, 22529 Hamburg, Germany </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>16</volume><elocation-id>872</elocation-id><history><date date-type="received"><day>18</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>26</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Multimodality treatment improves the chance of survival but increases the risk for long-term side effects in young cancer survivors, so-called&#x0201d; Adolescents and Young Adults&#x0201c;(AYAs). Compared to the general population AYAs have a 5 to 15-fold increased risk of cardiovascular morbidity. Thus, improving modifiable lifestyle risk factors is of particular importance.</p></sec><sec><title>Methods</title><p>The INAYA trial included AYAs between 18 and 39 years receiving an intensified individual nutrition counseling at four time points in a 3-month period based on a 3-day dietary record. At week 0 and 12 AYAs got a face-to-face counseling, at week 2 and 6 by telephone. Primary endpoint was change in nutritional behavior measured by Healthy Eating Index - European Prospective Investigation into Cancer and Nutrition (HEI-EPIC).</p></sec><sec><title>Results</title><p>Twenty-three AYAs (11 female, 12 male, median age 20&#x000a0;years (range 19&#x02013;23&#x000a0;years), median BMI: 21.4&#x000a0;kg/m<sup>2</sup> (range: 19.7&#x02013;23.9&#x000a0;kg/m<sup>2</sup>) after completion of cancer treatment for sarcoma (<italic>n</italic>&#x02009;=&#x02009;2), carcinoma (<italic>n</italic>&#x02009;=&#x02009;2), blastoma (<italic>n</italic>&#x02009;=&#x02009;1), hodgkin lymphoma (<italic>n</italic>&#x02009;=&#x02009;12), or leukemia (<italic>n</italic>&#x02009;=&#x02009;6) were included (median time between diagnosis and study inclusion was 44&#x000a0;month).</p><p>The primary endpoint was met, with an improvement of 20 points in HEI-EPIC score in 52.2&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;12) of AYAs. At baseline, median HEI-EPIC score was 47.0 points (range from 40.0 to 55.0 points) and a good, moderate and bad nutritional intake was seen in 4.3, 73.9 and 21.7&#x000a0;% of AYAs. At week 12, median HEI-EPIC improved significantly to 65.0 points (range from 55.0 to 76.0 points) (<italic>p</italic>&#x02009;&#x02264;&#x02009;0.001) and a good, moderate and bad nutritional intake was seen in 47.8, 52.2 and 0&#x000a0;% of AYAs. No change was seen in quality of life, waist-hip ratio and blood pressure.</p></sec><sec><title>Conclusion</title><p>Intensified nutrition counseling is feasible and seem to improve nutritional behavior of AYAs. Further studies will be required to demonstrate long-term sustainability and confirm the results in a randomized design in larger cohorts.</p></sec><sec><title>Trial registration</title><p>Clinical trial identifier <ext-link ext-link-type="uri" xlink:href="https://drks-neu.uniklinik-freiburg.de/drks_web/navigate.do?navigationId=trial.HTML&#x00026;TRIAL_ID=DRKS00009883">DRKS00009883</ext-link> on DRKS</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12885-016-2896-7) contains supplementary material, which is available to authorized users.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Multimodality treatment, combining systemic and local therapies, offer an increasing number of patients the chance long-term survival or even cure. Currently, the number of cancer survivors is estimated to be about 15 million in the US rising to about 20 million within the next decade [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p>While improving treatment results and outcome on the one side, multimodality treatment may also increase the risk for physiological, psychological and social long-term sequelae on the other side. Adolescents and young adults (AYAs) receiving their cancer treatment during childhood are at particular risk for long-term side effects. According to the Childhood Cancer Survivor study (CCSS, <italic>n</italic>&#x02009;=&#x02009;10,397) 2 out of 3 AYAs have treatment related long-term toxicities [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p>The major long-term toxicities and cause of mortality after treatment of childhood cancer are cardiovascular diseases like cardiomyopathy, chronic heart failure (CHF) and valvular problems [<xref ref-type="bibr" rid="CR3">3</xref>]. Compared to general population AYAs have a 5 to 15-fold increased risk of cardiovascular morbidity [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. The individual risk is determined by treatment related factors (e.g. type of chemotherapeutic agents, application schedule, number of cycles, cumulative dose of different agents, and combination with radiotherapy) and non-treatment related factors (nicotine abuse, diabetes mellitus, dyslipoproteinemia and hypertension [<xref ref-type="bibr" rid="CR6">6</xref>]. AYAs who have received anthracycline-based treatment combined with chest radiation possess the highest risk for cardiovascular late toxicity, which may further be enhanced by non-treatment related factors [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p>Whereas large clinical trials are conducted to improve patient outcome, both in terms of cure rates and reduction of long-term toxicities, prospective studies evaluating modifications of lifestyle factors as potential non-treatment related risk factors for long-term toxicity in AYAs are lacking.</p><p>In adult survivors of breast and prostate cancer some studies have demonstrated that physical activity and healthy eating can increase survival [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p><p>The WHEL study showed that telephone nutrition counseling can achieve major increases in the intake of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors [<xref ref-type="bibr" rid="CR9">9</xref>]. The ENRGY trial has shown that a behavioral weight loss intervention can lead to clinically meaningful weight loss in overweight/obese breast cancer survivors [<xref ref-type="bibr" rid="CR10">10</xref>]. However, with a median age at diagnosis of more than 60&#x000a0;years for these cancer survivors, the psychosocial background and living conditions largely differ from AYAs. Little is known about the feasibility and the effectiveness of a lifestyle intervention in an AYA population at risk for cardiovascular disease.</p><p>Furthermore, only 10&#x000a0;% of the cancer survivors are following a healthy lifestyle without any additional intervention [<xref ref-type="bibr" rid="CR11">11</xref>]. A large number of cancer survivors are overweight (58&#x000a0;%), eat less than 5 times per day fruits and vegetables (82&#x000a0;%) and perform no sport activities (55&#x000a0;%) [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p>The correlation between nutrition and cardiovascular disease in AYAs is unknown, but has been intensively studied in coronary heart disease (CHD) patients. For this patient group a relevant risk reduction for development of CHF by healthy nutrition was demonstrated (e.g. by 30&#x000a0;% with a Mediterranean diet or by 13&#x000a0;% following the criteria of &#x0201c;Dietary Approaches to Stop Hypertension&#x0201d;) [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. Both diets are rich of fibers, fruits and vegetables, which mirrors the nutrition recommendations of the &#x0201c;Deutsche Gesellschaft f&#x000fc;r Ern&#x000e4;hrung&#x0201d; (DGE) (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1 for recommendations of the DGE) [<xref ref-type="bibr" rid="CR15">15</xref>]. In CHD patients an intensive, individualized nutrition counseling leads to an improvement of nutritional status and behavior and finally quality of life [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p>The INAYA trial reported here was performed to evaluate the feasibility and the impact of an intensified nutrition counseling in the particularly at risk population of AYAs.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Trial eligibility</title><p>AYAs aged from 18 to 39&#x000a0;years with at least one treatment related (e.g. anthracycline based chemotherapy or chest radiation) or at least one non-treatment related (nicotine abuse, diabetes mellitus, dyslipoproteinemia or hypertension) risk factor for cardiovascular disease were eligible. All AYAs had completed cancer treatment with curative intent, were currently considered in remission and were receiving aftercare within our multidisciplinary survivorship clinic.</p><p>The trial was approved by the institutional review board and registered (Clinical trial identifier DRKS00009883 on DRKS). All patients provided written informed consent before study entry.</p></sec><sec id="Sec4"><title>Study design</title><p>Prior to baseline assessment and after 12&#x000a0;weeks the AYAs filled in a 3-day dietary record (&#x0201c;Freiburger Ern&#x000e4;hrungsprotokoll&#x0201d;) providing data to calculate the &#x0201c;Healthy Eating Index- European Prospective Investigation into Cancer and Nutrition&#x0201d; (HEI-EPIC) [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p>At baseline and after 12&#x000a0;weeks all AYAs got an intensified face-to-face nutrition counseling of 60&#x000a0;min performed by the same registered dietitian and based on the recommendations of the DGE (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1) [<xref ref-type="bibr" rid="CR15">15</xref>]. Depending on the HEI-EPIC results and reported nutrition problems, recommendations of the DGE were modified and individually tailored to the needs of every AYA. Additionally, demographic information and medical history was collected at baseline. Waist-hip ratio (WHR), body mass index (BMI), blood pressure (RR), health-related quality of life (HRQOL, measured by EORTC QLQ-C30 [<xref ref-type="bibr" rid="CR17">17</xref>]) and laboratory parameters (AST, ALT, HbA1c, total cholesterol, HDL-cholesterol, LDL-cholesterol, C-reactive protein (CrP)) were assessed at baseline and after 12&#x000a0;weeks. At weeks 2 and six nutrition counseling of 30&#x000a0;min was repeated by telephone. (see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> for study flowchart).<fig id="Fig1"><label>Fig. 1</label><caption><p>Study design</p></caption><graphic xlink:href="12885_2016_2896_Fig1_HTML" id="MO1"/></fig>
</p></sec><sec id="Sec5"><title>Healthy eating index - European prospective investigation into cancer and nutrition</title><p>HEI-EPIC is an established instrument to evaluate the dietary behavior [<xref ref-type="bibr" rid="CR18">18</xref>]. In the present pilot study the validated German version of HEI, the HEI-EPIC was used [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p>The HEI-EPIC distinguishes the following eight food groups: drinks, vegetables, fruits, cereals/potatoes, milk/dairy products, meat/sausages/fish/eggs, fats/oil and sweets/snacks. Based on a calculation described by R&#x000fc;sten et al. 0&#x02013;10 points for each group of food with up to 20 points for fruits, vegetables and drinks were calculated [<xref ref-type="bibr" rid="CR16">16</xref>]. The sum score range from 0 to 110 points. A sum score&#x02009;&#x02264;&#x02009;40 points indicate a bad, &#x0003e; 40&#x02013;64 points a moderate and&#x02009;&#x02265;&#x02009;65 points a good dietary behavior [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec6"><title>Statistics</title><p>The primary endpoint was the rate of AYAs with a relevant improvement in nutritional behavior measured by HEI-EPIC (increase of at least 20 points) between weeks 0 and 12. Secondary endpoints were the change in median HEI-EPIC, the assessment of HRQOL by the EORTC QLQ-C30, WHR, BMI, RR and laboratory assessment regarding dyslipoproteinemia and cholesterinemia. Pre-post differences of the secondary endpoints were analyzed with Wilcoxon test for depended samples in an exploratory fashion. In addition, retrospective BMI sub groups were evaluated and patients were classified as: underweight (&#x02264;18.49&#x000a0;kg/m<sup>2</sup>; <italic>n</italic>&#x02009;=&#x02009;5), normal weight (&#x0003e;18.5&#x02013;24.99&#x000a0;kg/m<sup>2</sup>; <italic>n</italic>&#x02009;=&#x02009;14) and overweight/obese (&#x02265; 25.0&#x02013;44.99&#x000a0;kg/m<sup>2</sup>; <italic>n</italic>&#x02009;=&#x02009;4). No formal comparison of BMI subgroups was performed due to small numbers.</p></sec><sec id="Sec7"><title>Sample size calculation</title><p>Based on our experience in the survivorship clinic, about 25&#x000a0;% of patients improve their nutritional behavior (increase in 20 points in HEI-EPIC) after a general nutrition counseling. With the intensive, individualized nutrition counseling at least 50&#x000a0;% of AYAs should improve their nutritional intake by 20 points on HEI-EPIC to regard the intervention as meaningful. The probability to accept the intervention as promising (improvement rate &#x02265;50&#x000a0;% of AYAs), in spite of a true improvement rate of &#x02264;25&#x000a0;% only, was set at 0.1 (type I error). The probability to erroneously reject the intervention as not sufficiently efficient (&#x02264;25&#x000a0;%), although the true improvement rate is meaningful (&#x02265;50&#x000a0;%) was set at 0.2 (type II error, corresponding to a power of 80&#x000a0;%). According to these parameters and using a standard single-stage phase II design with a one sided test and including 10&#x000a0;% drop outs, <italic>n</italic>&#x02009;=&#x02009;21 AYAs had to be recruited [<xref ref-type="bibr" rid="CR20">20</xref>].</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Patients&#x02019; characteristics</title><p>Twenty-three AYAs, 11 female and 12 male, were included in the INAYA study. Median age of cancer diagnosis was 16.0&#x000a0;years (range: 10.0&#x02013;17.0&#x000a0;years), median age at time of study inclusion was 20.0&#x000a0;years (range: 19.0&#x02013;23.0&#x000a0;years). Median time between diagnosis and study inclusion was 44&#x000a0;months (range: 11.0&#x02013;237&#x000a0;months). Cancer diagnosis included sarcoma (<italic>n</italic>&#x02009;=&#x02009;2), carcinoma (<italic>n</italic>&#x02009;=&#x02009;2), blastoma (<italic>n</italic>&#x02009;=&#x02009;1), hodgkin lymphoma (<italic>n</italic>&#x02009;=&#x02009;12), or leukemia (<italic>n</italic>&#x02009;=&#x02009;6).</p><p>All AYAs (100&#x000a0;%) presented treatment related risks factors for cardiovascular diseases that were application of anthracyclines (<italic>n</italic>&#x02009;=&#x02009;22, 95.7&#x000a0;%), chest radiation (<italic>n</italic>&#x02009;=&#x02009;9, 39.1&#x000a0;%) or both (<italic>n</italic>&#x02009;=&#x02009;14, 60.9&#x000a0;%). Additional 8 (34.8&#x000a0;%) AYAs had non-treatment related risk factors: smoking (<italic>n</italic>&#x02009;=&#x02009;5, 21.7&#x000a0;%), overweight with BMI&#x02009;&#x0003e;&#x02009;25.0&#x000a0;kg/m<sup>2</sup> (<italic>n</italic>&#x02009;=&#x02009;4, 17.4&#x000a0;%) and hypertension (<italic>n</italic>&#x02009;=&#x02009;1, 4.3&#x000a0;%), but no diabetes mellitus (<italic>n</italic>&#x02009;=&#x02009;0, 0&#x000a0;%). One AYA had more than one non-treatment related risk factor.</p><p>Compliance rate was 100&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;23) at baseline and week 2 but decreased to 73.9&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;17) at week 6 and 69.6&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;16) at week 12. Therefore, overall attrition rate was 30&#x000a0;%. Reasons for drop out were disease relapse (<italic>n</italic>&#x02009;=&#x02009;1), lack of time due to high work load (<italic>n</italic>&#x02009;=&#x02009;1), lack of time due other reasons (<italic>n</italic>&#x02009;=&#x02009;3) and two were lost to follow up.</p></sec><sec id="Sec10"><title>Primary endpoint</title><p>In 52.2&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;12) of AYAs the median HEI-EPIC score improved by more than 20 points from baseline to week 12. Thus, the primary endpoint of an improvement in nutritional behavior by more than 20 points in more than 50&#x000a0;% of AYAs measured by HEI-EPIC was met, demonstrating the feasibility of the intensive, individualized nutrition counseling and a high rate of improvement in nutritional behavior.</p></sec><sec id="Sec11"><title>Secondary endpoints</title><sec id="Sec12"><title>HEI-EPIC</title><p>At baseline, the median HEI-EPIC score was 47.0 points (range: 40.0&#x02013;55.0 points) representing a moderate dietary behavior. A good, moderate and bad nutritional intake was seen in 4.3, 73.9 and 21.7&#x000a0;% of AYAs. At week 12, median HEI-EPIC score improved significantly to 65.0 points (range: 55.0&#x02013;76.0 points) (<italic>p</italic>&#x02009;&#x02264;&#x02009;0.001) representing a good dietary behavior. Good, moderate and bad nutritional intake was seen in 47.8, 52.2 and 0&#x000a0;% of AYAs (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Nutritional behavior in AYAs at baseline and week 12</p></caption><graphic xlink:href="12885_2016_2896_Fig2_HTML" id="MO2"/></fig>
</p><p>Nutrition scores improved significantly in all food groups, except meat/sausages/fish/eggs/soy products and fats/oil (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Change in median nutrition intake of different HEI-EPIC food groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Food groups</th><th>Week 0 (T0)</th><th>Week 12 (T3)</th><th>
<italic>p</italic>-value</th></tr></thead><tbody><tr><td>drinks</td><td>4.8 (3.3&#x02013;9.3)</td><td>8.4 (6.9&#x02013;10.1)</td><td char="." align="char">0.001</td></tr><tr><td>vegetables</td><td>1.8 (0.8&#x02013;2.4)</td><td>3.1 (1.7&#x02013;3.9)</td><td char="." align="char">0.001</td></tr><tr><td>fruits</td><td>1.5 (0.0&#x02013;2.4)</td><td>2.4 (0.5&#x02013;3.6)</td><td char="." align="char">0.030</td></tr><tr><td>cereals/cereals products/potatoes</td><td>2.3 (1.7&#x02013;2.9)</td><td>2.9 (2.3&#x02013;3.4)</td><td char="." align="char">0.038</td></tr><tr><td>milk/milk products/dairy products</td><td>3.3 (1.3&#x02013;2.9)</td><td>1.8 (1.6&#x02013;3.9)</td><td char="." align="char">0.041</td></tr><tr><td>meat/sausages/fish/eggs/soy products</td><td>1.2 (0.7&#x02013;1.8)</td><td>1.5 (0.8&#x02013;1.8)</td><td char="." align="char">0.452</td></tr><tr><td>fats/oil</td><td>1.6 (1.2&#x02013;2.2)</td><td>2.1 (1.8&#x02013;2.6)</td><td char="." align="char">0.178</td></tr><tr><td>sweets/snacks/alcohol</td><td>2.4 (1.4&#x02013;2.8)</td><td>0.9 (0.6&#x02013;1.8)</td><td char="." align="char">0.001</td></tr></tbody></table></table-wrap>
</p><p>HEI-EPIC score numerically improved in all BMI subgroups (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>HEI-EPIC of different BMI groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th>BMI groups</th><th>HEI-EPIC score week 0 (T0)</th><th>HEI-EPIC score week 12 (T3)</th></tr></thead><tbody><tr><td>underweight AYAs:</td><td rowspan="2">49.0 (38.0&#x02013;57.5)</td><td rowspan="2">78.0 (57.0&#x02013;80.5)</td></tr><tr><td>BMI &#x0003c;18.5&#x000a0;kg/m<sup>2</sup>
<break/>(<italic>n</italic>&#x02009;=&#x02009;5)</td></tr><tr><td>normal weight AYAs:</td><td rowspan="2">50.5 (45.8&#x02013;56.3)</td><td rowspan="2">62.5 (53.3&#x02013;72.3)</td></tr><tr><td>BMI &#x02265;18.5&#x02013;24.9&#x000a0;kg/m<sup>2</sup>
<break/>(<italic>n</italic>&#x02009;=&#x02009;14)</td></tr><tr><td>overweight AYAs:</td><td rowspan="2">37.5 (27.3&#x02013;44.0)</td><td rowspan="2">60.0 (49.8&#x02013;69.5)</td></tr><tr><td>BMI &#x02265;25.0&#x000a0;kg/m<sup>2</sup>
<break/>(<italic>n</italic>&#x02009;=&#x02009;4)</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec13"><title>Quality of life</title><p>For quality of life analysis we used the global health status/quality of life (GHS/QOL) score of the EORTC QLQ C-30 questionnaire. The median GHS/QOL score did not change and was 83.3 points (range: 66.7&#x02013;91.7 points) at week 0 and 83.3 points (range: 66.7&#x02013;91.7 points) at week 12 (<italic>p</italic>&#x02009;=&#x02009;0.332) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). A clinical relevant improvement of GHS/QOL score (&#x02265; 10 points) was seen in 21.7&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;5) of AYAs. While normal weight patients did not improve their median GHS/QoL (83.3 at week 0 and 12), patients of under- or overweight seemed to increase the GHS/QoL score (underweight: 66.7 to 83.3; overweight 75.0 to 87.5 from week 0 to 12). Detailed results for functioning, symptom and single item scores of the EORTC QLQ C-30 questionnaire are shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Secondary endpoints: quality of life, BMI, blood pressure and WHR</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Selected secondary endpoints</th><th>Week 0 (T0)</th><th>Week 12 (T3)</th><th>
<italic>p</italic>-value</th></tr></thead><tbody><tr><td>BMI (kg/m<sup>2</sup>)</td><td>21.4 (19.7&#x02013;23.9)</td><td>20.4 (19.0&#x02013;23.9)</td><td>0.218</td></tr><tr><td>Quality of life (GHS/QoL points)</td><td>83.3 (66.7&#x02013;91.7)</td><td>83.3 (66.7&#x02013;91.7)</td><td>0.332</td></tr><tr><td>Blood pressure (mmHg)</td><td>110/70 (105&#x02013;135/60&#x02013;90)</td><td>110/75 (95&#x02013;135/60&#x02013;90)</td><td>0.015/0.605</td></tr><tr><td>Waist hip ratio (WHR)</td><td>0.80 (0.69&#x02013;0.97)</td><td>0.77 (0.66&#x02013;0.98)</td><td>0.349</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec14"><title>Body Mass Index (BMI)</title><p>At baseline 5 AYAs were underweight, 14 AYAs normal weight and 4 AYAs overweight according to WHO criteria. After nutrition counseling at week 12, the amount of normal weight AYAs increased to 17, with only four underweight and two overweight/obese AYAs remaining.</p><p>Before nutrition counseling 5 patients claimed weight loss as one of the goals of taking part in that trial. All of them reached their aim to lose weight. The overweight/obese patients (<italic>n</italic>&#x02009;=&#x02009;4) lost a median of 4.3&#x000a0;kg (range: 1.4&#x02013;7.9&#x000a0;kg).</p><p>The median BMI at baseline was 21.4&#x000a0;kg/m<sup>2</sup> (range: 19.7&#x02013;23.9&#x000a0;kg/m<sup>2</sup>) and 20.4&#x000a0;kg/m<sup>2</sup> (range: 19.0&#x02013;23.9&#x000a0;kg/m<sup>2</sup>) at week 12 (<italic>p</italic>&#x02009;=&#x02009;0.218) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). In underweight and normal weight patients the median BMI remained unaffected 17.7&#x000a0;kg/m<sup>2</sup> (range: 16.8&#x02013;18.0&#x000a0;kg/m<sup>2</sup>) and 21.4&#x000a0;kg/m<sup>2</sup> (range: 20.0&#x02013;23.4&#x000a0;kg/m<sup>2</sup>) at baseline and 17.7&#x000a0;kg/m<sup>2</sup> (range: 16.8&#x02013;18.2&#x000a0;kg/m<sup>2</sup>) and 20.7&#x000a0;kg/m<sup>2</sup> (range: 20.0&#x02013;23.2&#x000a0;kg/m<sup>2</sup>) at week 12, respectively. In overweight patients a slight decrease in median BMI from 29.1&#x000a0;kg/m<sup>2</sup> (range: 25.2&#x02013;40.0&#x000a0;kg/m<sup>2</sup>) to 27.3&#x000a0;kg/m<sup>2</sup> (range: 24.6&#x02013;37.8&#x000a0;kg/m<sup>2</sup>) was noted.</p></sec><sec id="Sec15"><title>Blood pressure (RR)</title><p>During the 12&#x000a0;weeks intervention period the median RR remained stable with 110/70&#x000a0;mmHg (range: 110&#x02013;125/70&#x02013;80&#x000a0;mmHg) at baseline and 110/75&#x000a0;mmHg (range: 105&#x02013;125/70&#x02013;80&#x000a0;mmHg) at week 12 (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).</p></sec><sec id="Sec16"><title>Waist-hip ratio (WHR)</title><p>All patients WHR were within the normal range &#x0003c;0.85 for women and &#x0003c;1.0 for men. Median WHR did not change significantly from baseline to week 12, neither in the overall population nor in the BMI subgroups.</p><p>Median WHR was 0.80 (range: 0.72&#x02013;0.80) at baseline and 0.77 (range: 0.71&#x02013;0.80) at week 12 (<italic>p</italic>&#x02009;=&#x02009;0.349). 65.2&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;15) had a lower and 30.4&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;7) had a higher WHR in week 12 (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). No relevant differences in WHR changes over time were noted within the BMI subgroups.</p></sec><sec id="Sec17"><title>Biochemical parameters (AST, ALT, HbA1c, total cholesterol, HDL-cholesterol, LDL-cholesterol, CRP)</title><p>Intensified nutrition counseling had no significant effect on biochemical parameters. Detailed results for AST and ALT, HbA1c, total-cholesterol, LDL-cholesterol, HDL-cholesterol and CRP are shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3.</p></sec></sec></sec><sec id="Sec18"><title>Discussion</title><p>This first, prospective life-style modification trial in the particular patient group of AYAs demonstrate the feasibility of an intensified, individual nutrition counseling and results in high rates of improvement in nutritional behavior. An improvement of more than 20 points was seen in 52.2&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;12) of the AYAs. Thus, the primary endpoint of this study was met. The median HEI-EPIC score changed significantly from a moderate (47.0 points) to a good nutritional behavior (65.0 points). Overall, the number of AYAs with good nutritional behavior was increased by the INAYA intervention from one to 11.</p><p>The AYA population relevantly differs from the elderly survivor patients and prospective trials in this distinct setting are lacking. AYAs have to deal with a variety of relevant problems including educational and occupational issues, partnership and family planning, besides lifestyle and nutrition. Of note, compared to previously reported rates of healthy food intake of up to 18&#x000a0;% in elderly cancer survivors without nutrition counseling, the baseline rate in our population seemed to be even lower (<italic>n</italic>&#x02009;=&#x02009;1, 4.3&#x000a0;%) [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p>Despite the particular vulnerability of the AYA population prospective trials about nutrition counseling are lacking. The majority of published nutrition intervention trials include either non-AYA or non-cancer patients. Nevertheless, similar to the INAYA trial, a large variety of trials in different patient population could demonstrate the feasibility and efficacy of lifestyle interventions.</p><p>A review of 21 trials about nutrition counseling in primary care setting demonstrated that moderate- or high-intensity counseling interventions, including use of interactive health communication tools, can reduce the consumption of saturated fat and increase the intake of fruit and vegetable and therefore improve nutritional behavior. The patient population included was very heterogeneous and is not comparable to AYAs [<xref ref-type="bibr" rid="CR21">21</xref>]. In breast cancer patients, a randomized interventional trial showed a significant improvement in vegetable consumption 8&#x000a0;weeks after nutrition counseling [<xref ref-type="bibr" rid="CR22">22</xref>]. In regard of dietary behavior, the best-investigated patient groups are those with hypertension or coronary heart disease (CHD). In these groups structured educational programs and intensified nutrition counseling improve dietary behavior and quality of life [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p>Although survivors usually have an increased risk of poor HRQOL, the baseline GHS/QoL score was relatively high (83.3 points) in our cohort [<xref ref-type="bibr" rid="CR24">24</xref>]. HRQOL assessment refers to a multidimensional construct, considering the subjective perceptions of disease symptoms, treatment side effects as well as physical, emotional, social and cognitive functions. Therefore, it might be difficult to improve the overall HRQOL by the improvement of nutritional behavior.</p><p>Limitations of the INAYA study are the relatively low number of participants, limiting the interpretation of results particularly of the subgroup evaluations. Furthermore, the attrition rate of 30&#x000a0;% limits the follow up data. The availability for phone consultations was limited, mainly due to educational or occupational engagements of our AYA patients. Therefore, for future trials the follow up procedures should be carefully evaluated. One way could be to send nutrition information and reminders by e-Mail, Apps or SMS. Another possibility could be to extend the intervals and re-counsel the AYAs at the next regular aftercare appointment. The relatively short intervention and follow up period does not allow evaluating the sustained efficacy of the INAYA protocol. Further trials will need to confirm the sustainability of the INAYA approach, although periodical re-counseling will likely be necessary to ensure long-term healthy eating. Due to the single arm design a control-group is missing and the efficacy of the INAYA approach cannot be demonstrated. However, a high rate of 50&#x000a0;% of AYAs with an improvement in nutritional behavior was noted, clearly pointing towards further evaluation of the INAYA approach in a randomized setting.</p></sec><sec id="Sec19"><title>Conclusion</title><p>Intensified nutrition counseling is feasible and seem to improve short-term dietary behavior of AYAs and thus potentially reduces the long-term risk for developing cardiovascular diseases. Thus, intensified lifestyle modification approaches flanked by long-term follow up are required in AYAs.</p></sec></body><back><app-group><app id="App1"><sec id="Sec20"><title>Additional file</title><p>
<media position="anchor" xlink:href="12885_2016_2896_MOESM1_ESM.docx" id="MOESM1"><label>Additional file 1: Table S1.</label><caption><p>10 guidelines of the German Nutrition Society (DGE) for a wholesome diet. <bold>Table S2</bold>. Results of EORTC QLQ C-30 questionnaire. <bold>Table S3</bold>. Change in blood values ASAT, ALAT, HbA1c, Total cholesterol, LDL-cholesterol, HDL-cholesterol and CrP. (DOCX 17&#x000a0;kb)</p></caption></media>
</p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>ALT</term><def><p>Alanine aminotransferase</p></def></def-item><def-item><term>AST</term><def><p>Aspartate aminotransferase</p></def></def-item><def-item><term>AYA</term><def><p>Adolescents and young adults</p></def></def-item><def-item><term>BMI</term><def><p>Body mass index</p></def></def-item><def-item><term>CCSS</term><def><p>Childhood cancer survivor study</p></def></def-item><def-item><term>CHD</term><def><p>Chronic heart disease</p></def></def-item><def-item><term>CHF</term><def><p>Chronic heart failure</p></def></def-item><def-item><term>CRP</term><def><p>C-reactive protein</p></def></def-item><def-item><term>DGE</term><def><p>&#x0201c;Deutsche gesellschaft f&#x000fc;r ern&#x000e4;hrung&#x0201d;</p></def></def-item><def-item><term>DRKS</term><def><p>Deutsches register klinischer studien</p></def></def-item><def-item><term>e.g.</term><def><p>Exempli gratia</p></def></def-item><def-item><term>EORTC QLQ-C30</term><def><p>European Organisation for Research and Treatment of Cancer Qualitiy of Life Core Questionnaire 30</p></def></def-item><def-item><term>GHS/QOL</term><def><p>Global health status/quality of life</p></def></def-item><def-item><term>HbA1c</term><def><p>Hemoglobin A1c</p></def></def-item><def-item><term>HDL-cholesterol</term><def><p>High-density lipoprotein cholesterol</p></def></def-item><def-item><term>HEI-EPIC</term><def><p>Healthy eating index - European prospective investigation into cancer and nutrition</p></def></def-item><def-item><term>HRQOL</term><def><p>Health-related quality of life</p></def></def-item><def-item><term>INAYA</term><def><p>Improved nutrition in AYAs</p></def></def-item><def-item><term>LDL-cholesterol</term><def><p>Low-density lipoprotein cholesterol</p></def></def-item><def-item><term>RR</term><def><p>Blood pressure</p></def></def-item><def-item><term>S</term><def><p>Supplement</p></def></def-item><def-item><term>WHR</term><def><p>Waist-hip ratio</p></def></def-item></def-list></glossary><ack><p>We want to thank all patients who participated in this study, all participating clinicians who included patients, and all the staff engaged in this study.</p><sec id="FPar1"><title>Funding</title><p>The study and manuscript was prepared without any funding or contribution of persons not mentioned in the authors&#x02019; section.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>For dataset supporting the conclusions of this article please contact the author.</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p>JQ, JG, BK, GE, AS recruited patients, collected patient data, interpreted results of analyses, prepared, reviewed and input into each stage of the manuscript; GS, LV, DB, CB: interpreted results of analyses, prepared, reviewed and input into each stage of the manuscript; All authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests. The authors alone are responsible for the content and writing of the paper.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>The trial was performed in accordance with the Declaration of Helsinki and has been approved by the local ethics committee &#x0201c;Ethik-Kommission der &#x000c4;rztekammer Hamburg&#x0201d; on 19/05/2015 (reference number PV4978). Informed consent to participate in the INAYA study and to publish the results were obtained from all participants before study inclusion.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSantis</surname><given-names>CE</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Mariotto</surname><given-names>AB</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Stein</surname><given-names>KD</given-names></name><name><surname>Kramer</surname><given-names>JL</given-names></name><name><surname>Alteri</surname><given-names>R</given-names></name><name><surname>Robbins</surname><given-names>AS</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer treatment and survivorship statistics, 2014</article-title><source>CA Cancer J Clin</source><year>2014</year><volume>64</volume><issue>4</issue><fpage>252</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.3322/caac.21235</pub-id><pub-id pub-id-type="pmid">24890451</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolff</surname><given-names>SN</given-names></name><name><surname>Nichols</surname><given-names>C</given-names></name><name><surname>Ulman</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Kho</surname><given-names>S</given-names></name><name><surname>Lofye</surname><given-names>D</given-names></name><name><surname>Milford</surname><given-names>M</given-names></name><name><surname>Tracy</surname><given-names>D</given-names></name><name><surname>Bellavia</surname><given-names>B</given-names></name><name><surname>Armstrong</surname><given-names>L</given-names></name></person-group><article-title>Survivorship: an unmet need of the patient with cancer - implications of a survey of the Lance Armstrong Foundation (LAF)</article-title><source>J Clin Oncol</source><year>2005</year><volume>23</volume><issue>16_suppl</issue><fpage>6032</fpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oeffinger</surname><given-names>KC</given-names></name><name><surname>Mertens</surname><given-names>AC</given-names></name><name><surname>Sklar</surname><given-names>CA</given-names></name><name><surname>Kawashima</surname><given-names>T</given-names></name><name><surname>Hudson</surname><given-names>MM</given-names></name><name><surname>Meadows</surname><given-names>AT</given-names></name><name><surname>Friedman</surname><given-names>DL</given-names></name><name><surname>Marina</surname><given-names>N</given-names></name><name><surname>Hobbie</surname><given-names>W</given-names></name><name><surname>Kadan-Lottick</surname><given-names>NS</given-names></name><etal/></person-group><article-title>Chronic health conditions in adult survivors of childhood cancer</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><issue>15</issue><fpage>1572</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1056/NEJMsa060185</pub-id><pub-id pub-id-type="pmid">17035650</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellino</surname><given-names>SM</given-names></name><name><surname>Geiger</surname><given-names>AM</given-names></name><name><surname>Mertens</surname><given-names>AC</given-names></name><name><surname>Leisenring</surname><given-names>WM</given-names></name><name><surname>Tooze</surname><given-names>JA</given-names></name><name><surname>Goodman</surname><given-names>P</given-names></name><name><surname>Stovall</surname><given-names>M</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name><name><surname>Hudson</surname><given-names>MM</given-names></name></person-group><article-title>Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study</article-title><source>Blood</source><year>2011</year><volume>117</volume><issue>6</issue><fpage>1806</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-04-278796</pub-id><pub-id pub-id-type="pmid">21037086</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulrooney</surname><given-names>DA</given-names></name><name><surname>Yeazel</surname><given-names>MW</given-names></name><name><surname>Kawashima</surname><given-names>T</given-names></name><name><surname>Mertens</surname><given-names>AC</given-names></name><name><surname>Mitby</surname><given-names>P</given-names></name><name><surname>Stovall</surname><given-names>M</given-names></name><name><surname>Donaldson</surname><given-names>SS</given-names></name><name><surname>Green</surname><given-names>DM</given-names></name><name><surname>Sklar</surname><given-names>CA</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort</article-title><source>BMJ</source><year>2009</year><volume>339</volume><fpage>b4606</fpage><pub-id pub-id-type="doi">10.1136/bmj.b4606</pub-id><pub-id pub-id-type="pmid">19996459</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tukenova</surname><given-names>M</given-names></name><name><surname>Guibout</surname><given-names>C</given-names></name><name><surname>Oberlin</surname><given-names>O</given-names></name><name><surname>Doyon</surname><given-names>F</given-names></name><name><surname>Mousannif</surname><given-names>A</given-names></name><name><surname>Haddy</surname><given-names>N</given-names></name><name><surname>Guerin</surname><given-names>S</given-names></name><name><surname>Pacquement</surname><given-names>H</given-names></name><name><surname>Aouba</surname><given-names>A</given-names></name><name><surname>Hawkins</surname><given-names>M</given-names></name><etal/></person-group><article-title>Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer</article-title><source>J Clin Oncol</source><year>2010</year><volume>28</volume><issue>8</issue><fpage>1308</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1200/JCO.2008.20.2267</pub-id><pub-id pub-id-type="pmid">20142603</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>RE</given-names></name><name><surname>Cadmus</surname><given-names>LA</given-names></name><name><surname>Emond</surname><given-names>JA</given-names></name><name><surname>Pierce</surname><given-names>JP</given-names></name></person-group><article-title>Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature</article-title><source>Maturitas</source><year>2010</year><volume>66</volume><issue>1</issue><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2010.01.004</pub-id><pub-id pub-id-type="pmid">20097494</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>CL</given-names></name><name><surname>Demark-Wahnefried</surname><given-names>W</given-names></name></person-group><article-title>Can lifestyle modification increase survival in women diagnosed with breast cancer?</article-title><source>J Nutr</source><year>2002</year><volume>132</volume><issue>11 Suppl</issue><fpage>3504S</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12421877</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>JP</given-names></name><name><surname>Newman</surname><given-names>VA</given-names></name><name><surname>Flatt</surname><given-names>SW</given-names></name><name><surname>Faerber</surname><given-names>S</given-names></name><name><surname>Rock</surname><given-names>CL</given-names></name><name><surname>Natarajan</surname><given-names>L</given-names></name><name><surname>Caan</surname><given-names>BJ</given-names></name><name><surname>Gold</surname><given-names>EB</given-names></name><name><surname>Hollenbach</surname><given-names>KA</given-names></name><name><surname>Wasserman</surname><given-names>L</given-names></name><etal/></person-group><article-title>Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors</article-title><source>J Nutr</source><year>2004</year><volume>134</volume><issue>2</issue><fpage>452</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14747688</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>CL</given-names></name><name><surname>Flatt</surname><given-names>SW</given-names></name><name><surname>Byers</surname><given-names>TE</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Demark-Wahnefried</surname><given-names>W</given-names></name><name><surname>Ganz</surname><given-names>PA</given-names></name><name><surname>Wolin</surname><given-names>KY</given-names></name><name><surname>Elias</surname><given-names>A</given-names></name><name><surname>Krontiras</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors</article-title><source>J Clin Oncol</source><year>2015</year><volume>33</volume><issue>28</issue><fpage>3169</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1200/JCO.2015.61.1095</pub-id><pub-id pub-id-type="pmid">26282657</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>DK</given-names></name><name><surname>Terrin</surname><given-names>NC</given-names></name><name><surname>Menon</surname><given-names>U</given-names></name><name><surname>Kreps</surname><given-names>GL</given-names></name><name><surname>McCance</surname><given-names>K</given-names></name><name><surname>Parsons</surname><given-names>SK</given-names></name><name><surname>Mooney</surname><given-names>KH</given-names></name></person-group><article-title>Health behaviors in cancer survivors</article-title><source>Oncol Nurs Forum</source><year>2007</year><volume>34</volume><issue>3</issue><fpage>643</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1188/07.ONF.643-651</pub-id><pub-id pub-id-type="pmid">17573323</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>GT</given-names></name><name><surname>Oeffinger</surname><given-names>KC</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Kawashima</surname><given-names>T</given-names></name><name><surname>Yasui</surname><given-names>Y</given-names></name><name><surname>Leisenring</surname><given-names>W</given-names></name><name><surname>Stovall</surname><given-names>M</given-names></name><name><surname>Chow</surname><given-names>EJ</given-names></name><name><surname>Sklar</surname><given-names>CA</given-names></name><name><surname>Mulrooney</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Modifiable risk factors and major cardiac events among adult survivors of childhood cancer</article-title><source>J Clin Oncol</source><year>2013</year><volume>31</volume><issue>29</issue><fpage>3673</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1200/JCO.2013.49.3205</pub-id><pub-id pub-id-type="pmid">24002505</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>EJ</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Kremer</surname><given-names>LC</given-names></name><name><surname>Breslow</surname><given-names>NE</given-names></name><name><surname>Hudson</surname><given-names>MM</given-names></name><name><surname>Armstrong</surname><given-names>GT</given-names></name><name><surname>Border</surname><given-names>WL</given-names></name><name><surname>Feijen</surname><given-names>EA</given-names></name><name><surname>Green</surname><given-names>DM</given-names></name><name><surname>Meacham</surname><given-names>LR</given-names></name><etal/></person-group><article-title>Individual prediction of heart failure among childhood cancer survivors</article-title><source>J Clin Oncol</source><year>2014</year><volume>10</volume><fpage>3643</fpage><lpage>50</lpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipshultz</surname><given-names>SE</given-names></name><name><surname>Adams</surname><given-names>MJ</given-names></name><name><surname>Colan</surname><given-names>SD</given-names></name><name><surname>Constine</surname><given-names>LS</given-names></name><name><surname>Herman</surname><given-names>EH</given-names></name><name><surname>Hsu</surname><given-names>DT</given-names></name><name><surname>Hudson</surname><given-names>MM</given-names></name><name><surname>Kremer</surname><given-names>LC</given-names></name><name><surname>Landy</surname><given-names>DC</given-names></name><name><surname>Miller</surname><given-names>TL</given-names></name><etal/></person-group><article-title>Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association</article-title><source>Circulation</source><year>2013</year><volume>128</volume><issue>17</issue><fpage>1927</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1161/CIR.0b013e3182a88099</pub-id><pub-id pub-id-type="pmid">24081971</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>V.) GNSDGfEe</collab></person-group><source>10 guidelines of the German Nutrition Society (DGE) for a wholesome diet</source><year>2013</year><edition>9</edition></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruesten A</surname><given-names>V</given-names></name></person-group><article-title>Die Bewertung der Lebensmittelaufnahme mittels eines, Healthy Eating Index&#x02018;(HEI-EPIC)</article-title><source>Ern&#x000e4;hrungs Umschau</source><year>2009</year><volume>8</volume><fpage>450</fpage><lpage>6</lpage></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaronson</surname><given-names>NK</given-names></name><name><surname>Ahmedzai</surname><given-names>S</given-names></name><name><surname>Bergman</surname><given-names>B</given-names></name><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>Cull</surname><given-names>A</given-names></name><name><surname>Duez</surname><given-names>NJ</given-names></name><name><surname>Filiberti</surname><given-names>A</given-names></name><name><surname>Flechtner</surname><given-names>H</given-names></name><name><surname>Fleishman</surname><given-names>SB</given-names></name><name><surname>de Haes</surname><given-names>JC</given-names></name><etal/></person-group><article-title>The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology</article-title><source>J Natl Cancer Inst</source><year>1993</year><volume>85</volume><issue>5</issue><fpage>365</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1093/jnci/85.5.365</pub-id><pub-id pub-id-type="pmid">8433390</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guenther</surname><given-names>PM</given-names></name><name><surname>Casavale</surname><given-names>KO</given-names></name><name><surname>Reedy</surname><given-names>J</given-names></name><name><surname>Kirkpatrick</surname><given-names>SI</given-names></name><name><surname>Hiza</surname><given-names>HA</given-names></name><name><surname>Kuczynski</surname><given-names>KJ</given-names></name><name><surname>Kahle</surname><given-names>LL</given-names></name><name><surname>Krebs-Smith</surname><given-names>SM</given-names></name></person-group><article-title>Update of the Healthy Eating Index: HEI-2010</article-title><source>J Acad Nutr Diet</source><year>2013</year><volume>113</volume><issue>4</issue><fpage>569</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.jand.2012.12.016</pub-id><pub-id pub-id-type="pmid">23415502</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Center for Nutrition Policy and Promotion USDoA: The Healthy Eating Index: <ext-link ext-link-type="uri" xlink:href="http://www.cnpp.usda.gov/publications/hei/HEI89-90report.pdf">http://www.cnpp.usda.gov/publications/hei/HEI89-90report.pdf</ext-link>. 1995.</mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>TR</given-names></name></person-group><article-title>One-sample multiple testing procedure for phase II clinical trials</article-title><source>Biometrics</source><year>1982</year><volume>38</volume><issue>1</issue><fpage>143</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.2307/2530297</pub-id><pub-id pub-id-type="pmid">7082756</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignone</surname><given-names>MP</given-names></name><name><surname>Ammerman</surname><given-names>A</given-names></name><name><surname>Fernandez</surname><given-names>L</given-names></name><name><surname>Orleans</surname><given-names>CT</given-names></name><name><surname>Pender</surname><given-names>N</given-names></name><name><surname>Woolf</surname><given-names>S</given-names></name><name><surname>Lohr</surname><given-names>KN</given-names></name><name><surname>Sutton</surname><given-names>S</given-names></name></person-group><article-title>Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive Services Task Force</article-title><source>Am J Prev Med</source><year>2003</year><volume>24</volume><issue>1</issue><fpage>75</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/S0749-3797(02)00580-9</pub-id><pub-id pub-id-type="pmid">12554027</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Choi</surname><given-names>EJ</given-names></name><name><surname>Jeong</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>YK</given-names></name></person-group><article-title>Effect of 8-week nutrition counseling to increase phytochemical rich fruit and vegetable consumption in korean breast cancer patients: a randomized controlled trial</article-title><source>Clin Nutr Res</source><year>2014</year><volume>3</volume><issue>1</issue><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.7762/cnr.2014.3.1.39</pub-id><pub-id pub-id-type="pmid">24527419</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>SL</given-names></name><name><surname>Nasser</surname><given-names>R</given-names></name><name><surname>Comfort</surname><given-names>BL</given-names></name><name><surname>Larsen</surname><given-names>DK</given-names></name></person-group><article-title>Effect of nutrition counselling on client perceptions and eating behaviour</article-title><source>Can J Diet Pract Res</source><year>2006</year><volume>67</volume><issue>4</issue><fpage>171</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.3148/67.4.2006.171</pub-id><pub-id pub-id-type="pmid">17150138</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeltzer</surname><given-names>LK</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Leisenring</surname><given-names>W</given-names></name><name><surname>Tsao</surname><given-names>JCI</given-names></name><name><surname>Recklitis</surname><given-names>C</given-names></name><name><surname>Armstrong</surname><given-names>G</given-names></name><name><surname>Mertens</surname><given-names>AC</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name><name><surname>Ness</surname><given-names>KK</given-names></name></person-group><article-title>Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study</article-title><source>Cancer Epidemiol Biomark Prev</source><year>2008</year><volume>17</volume><issue>2</issue><fpage>435</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-07-2541</pub-id></element-citation></ref></ref-list></back></article>